Back to Savant Capital, LLC Savant Capital, LLC

AMLXAMLX

Showing 2 of 3 quarters

Position history for Savant Capital, LLCSavant Capital, LLC's holdings in AMYLYX PHARMACEUTICALS INC

No. Savant Capital exited its AMLX (Amylyx Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 57,565 shares worth $186,511. Savant Capital first reported AMLX in Q2 2024 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$186,511

Total Shares Change

-57,565

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$3.84
0
2024-Q3
Decreased
57,565
-40.0%
$186,5110.0%$3.08
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used